Veterinary Medicines

CANIWORM PLUS (150+144+50)MG/TAB ΔΙΣΚΙΟ

Authorised
  • Praziquantel
  • Pyrantel embonate
  • Fenbendazole
Download as PDF

Product identification

Medicine name:
CANIWORM PLUS (150+144+50)MG/TAB ΔΙΣΚΙΟ
Active substance:
  • Praziquantel
  • Pyrantel embonate
  • Fenbendazole
Target species:
  • Cat
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
  • Fenbendazole
    150.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Cat
      • Not applicable
        no withdrawal period
    • Dog
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 73491/19-06-2025/K-0267801
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 22/06/2023
Updated on: 27/06/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 22/06/2023
Updated on: 27/06/2023
Download